Gérard Soula, Adocia CEO,  summarizes the main recent events of Adocia during the Small Cap Event, during an interview with Didier Testot, financial journalist at La Bourse and La Vie.  
Shareholders are invited to attend our next Annual Shareholders’ meeting at 10 am at Hotel de Talleyrand, in the offices of Jones Day, 2 rue Saint Florentin, 75001 Paris. The notice of this shareholders’ meeting serving as convening notice is published on April 10th, 2019, in the French Bulletin des Annonces Légales Obligatoires (“BALO”), and
In partnership with Jaguar Network and the active participation of Adocia, Lyonbiopole “the French Health Cluster” invites its members to discover the challenges of data security. The digital transformation of healthcare companies today involves the multiplication of IoT infrastructures, the necessary remote hosting of data and the increase of file exchanges. In the face of
From Tuesday, March 26, 2019 to Friday, March 29, 2019, the Francophone Diabetes Society invites Diabetes specialists to share their progress during their Annual Congress. On this occasion, Adocia proposes three presentations: An Oral Communication by Dr. Grégory Meiffren,  27th March, 2019 11:00AM – 11:15AM in “auditorium 1200”. Theme: Comparaison des profils pharmacocinétiques et de pharmacodynamie

ATTD 2019: Abstracts details

Last February 20th until 23rd, Adocia team was attending #ATTD2019 in Berlin. ADOCIA presented 4 abstracts this year ; 2 Oral Presentations then 2 Posters as following: Poster # ATTD19-0194: BioChaperone Combo, A Co-Formulation Of Lispro And Glargine, Improves Postprandial Glucose Control Compared To Lispromix25 Or Lispro And Glargine Injections In Type 2 Diabetes Subjects Presenting Author:
Adocia to Present New Clinical Data on BioChaperone® Technology at the 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019) Advanced Technologies & Treatments for Diabetes (ATTD 2019) “The data presentations at the ATTD Annual Meeting demonstrate the potential of our BioChaperone technology to improve diabetes care and management,” commented Dr. Olivier
Steve Daly, Adocia US General Manager, will make a Presentation during The BIO CEO & Investor Conference, one of the largest investor conferences focused on established and emerging publicly traded and and select private biotech companies. This speaker’s sessions: New Treatments for Diabetes and Obesity: Innovations for Chronic Diseases      Date: Tuesday, February 12 9:00
Pharmapack Europe Event is dedicated to pharmaceutical packaging and drug delivery. Key event in Europe to meet innovating companies in  the field of pharmaceutical packaging, labelling, drug delivery device design, engineering and more.   https://www.pharmapackeurope.com/ Where: Paris Expo, Porte de Versailles, Hall 7.2 | Paris, France When: on February 6 and 7, 2019 – Paris  
Next January 28-30, 2019, ADOCIA will be attending the Drug Delivery Partnerships Event in Palm Beach Gardens (Florida, US). For 22 years, DDP has been the world’s largest drug delivery meeting place. DDP Website #DrugDelivery #NewTherapeuticAreas
Journalist Didier Testot interviewed Dr Olivier Soula, Deputy General Manager at Adocia, on key milestones achieved by the company in the past year and its outlook for 2019. You may watch the interview here: https://www.labourseetlavie.com : “Adocia is not for sale”. (French only) https://www.forum.oddo-bhf.com